SCHEMBL5226472

SCHEMBL5226472

COc1ccc(N(C(=O)O)c2nc3cc(N(C)c4ccnc(Nc5ccc(CS(N)(=O)=O)cc5)n4)ccc3n2C)c(C(C)(C)C)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 18/20 0.44
CYP3A4 P08684 3/20 0.44
CYP2D6 P10635 3/20 0.44
CYP2C9 P11712 3/20 0.44
CYP2C19 P33261 3/20 0.44
KIT P10721 5/20 0.40
PDGFRA P16234 5/20 0.40
AURKA O14965 3/20 0.40
RIPK1 Q13546 2/20 0.40
RIPK3 Q9Y572 2/20 0.40
BMPR1B O00238 1/20 0.40
PLK4 O00444 1/20 0.40
GAK O14976 1/20 0.40
EPHB6 O15197 1/20 0.40
ABCC4 O15439 1/20 0.40
RIPK2 O43353 1/20 0.40
CA12 O43570 1/20 0.40
PIP5K1C O60331 1/20 0.40
JAK2 O60674 1/20 0.40
STK16 O75716 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5223219 0.94 KDR (0.47) KDRCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL5227882 0.90 KDR (0.49) KDRCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL5226925 0.89 KDR (0.44) KDRCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL5227304 0.88 KDR (0.52) KDRCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL4977012 0.86 KDR (0.46) KDRCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL5227350 0.84 KDR (0.52) KDRCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL4982987 0.82 KDR (0.54) KDRCYP3A4CYP2D6CYP2C9CYP2C19
Trifluoroacetic Acid SCHEMBL5223205 0.82 KDR (0.48) KDRCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL4981188 0.80 KDR (0.49) KDRCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL4980896 0.80 KDR (0.52) KDRCYP3A4CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1487824-B1 DIAMINO-PYRIMIDINES AND THEIR USE AS ANGIOGENESIS INHIBITORS SMITHKLINE BEECHAM CORP (US) 2007-06-20 EP claimed